Joy Orient

Beijing Joy Orient Translational Medicine Research Center Co., Ltd. (formerly De Yi Orient) is a representative institution in China's precision medicine field, focusing on big data-driven precision medicine in genomics and life sciences, as well as precision targeted therapy and neoantigen immunotherapy for cancer. The company boasts a comprehensive product portfolio, offering one-stop solutions in precision medicine that span multiple areas including genetic disease diagnosis, birth defect prevention, oncology, chronic diseases, pharmacogenomics, and health management. In the field of genetic diseases, the company has established a genetic disease database for the Chinese population and developed a genomic big data diagnostic system. In oncology, the company pioneered panoramic gene sequencing and, in collaboration with its sister company, Beijing Chateau Medical Technology, advanced neoantigen-based cancer immunotherapy to achieve an integrated precision immuno-oncology solution. The company operates a high-throughput NOVAseq sequencing platform, a petabyte-scale big data analytics platform, and Beijing Quanpu Medical Laboratory Co., Ltd., which holds third-party medical testing qualifications.